<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:p="urn:schemas-microsoft-com:office:powerpoint" xmlns:a="urn:schemas-microsoft-com:office:access" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:s="uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs="urn:schemas-microsoft-com:rowset" xmlns:z="#RowsetSchema" xmlns:b="urn:schemas-microsoft-com:office:publisher" xmlns:ss="urn:schemas-microsoft-com:office:spreadsheet" xmlns:c="urn:schemas-microsoft-com:office:component:spreadsheet" xmlns:odc="urn:schemas-microsoft-com:office:odc" xmlns:oa="urn:schemas-microsoft-com:office:activation" xmlns:html="http://www.w3.org/TR/REC-html40" xmlns:q="http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc="http://microsoft.com/officenet/conferencing" xmlns:D="DAV:" xmlns:Repl="http://schemas.microsoft.com/repl/" xmlns:mt="http://schemas.microsoft.com/sharepoint/soap/meetings/" xmlns:x2="http://schemas.microsoft.com/office/excel/2003/xml" xmlns:ppda="http://www.passport.com/NameSpace.xsd" xmlns:ois="http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns:dir="http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds="http://www.w3.org/2000/09/xmldsig#" xmlns:dsp="http://schemas.microsoft.com/sharepoint/dsp" xmlns:udc="http://schemas.microsoft.com/data/udc" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:sub="http://schemas.microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec="http://www.w3.org/2001/04/xmlenc#" xmlns:sp="http://schemas.microsoft.com/sharepoint/" xmlns:sps="http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:udcs="http://schemas.microsoft.com/data/udc/soap" xmlns:udcxf="http://schemas.microsoft.com/data/udc/xmlfile" xmlns:udcp2p="http://schemas.microsoft.com/data/udc/parttopart" xmlns:wf="http://schemas.microsoft.com/sharepoint/soap/workflow/" xmlns:dsss="http://schemas.microsoft.com/office/2006/digsig-setup" xmlns:dssi="http://schemas.microsoft.com/office/2006/digsig" xmlns:mdssi="http://schemas.openxmlformats.org/package/2006/digital-signature" xmlns:mver="http://schemas.openxmlformats.org/markup-compatibility/2006" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns:mrels="http://schemas.openxmlformats.org/package/2006/relationships" xmlns:spwp="http://microsoft.com/sharepoint/webpartpages" xmlns:ex12t="http://schemas.microsoft.com/exchange/services/2006/types" xmlns:ex12m="http://schemas.microsoft.com/exchange/services/2006/messages" xmlns:pptsl="http://schemas.microsoft.com/sharepoint/soap/SlideLibrary/" xmlns:spsl="http://microsoft.com/webservices/SharePointPortalServer/PublishedLinksService" xmlns:Z="urn:schemas-microsoft-com:" xmlns:st="" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Texto de bal\00E3o Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
span.apple-style-span
{mso-style-name:apple-style-span;}
span.EstiloDeEmail19
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.TextodebaloChar
{mso-style-name:"Texto de bal\00E3o Char";
mso-style-priority:99;
mso-style-link:"Texto de bal\00E3o";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:70.85pt 3.0cm 70.85pt 3.0cm;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="2050" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=PT-BR link=blue vlink=purple style='word-wrap: break-word;-webkit-nbsp-mode: space;-webkit-line-break: after-white-space'><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Hi !<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>There are these papers about<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>These need a very critical reading to discuss<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>This discussion with all about the matter and these papers is very welcome! (at least for me!)<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Regards for all<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Luiz Ristow<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><div><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><img width=383 height=152 id="Imagem_x0020_1" src="cid:image001.gif@01CC7DCE.9D06DF30" alt="assinatura de email dr luiz"><o:p></o:p></span></p></div><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p> </o:p></span></p><div><div style='border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal><b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'>De:</span></b><span style='font-size:10.0pt;font-family:"Tahoma","sans-serif"'> leish-l-bounces@lineu.icb.usp.br [mailto:leish-l-bounces@lineu.icb.usp.br] <b>Em nome de </b>John David<br><b>Enviada em:</b> segunda-feira, 26 de setembro de 2011 18:44<br><b>Para:</b> Dr GR Rajasekariah<br><b>Cc:</b> leish-l@lineu.icb.usp.br; Carlos Gouvea; hubert mazure; smithyman@cellabs.com.au<br><b>Assunto:</b> Re: [Leish-l] testing vaccinated dogs for immunopotentiation<o:p></o:p></span></p></div></div><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>I think that for any vaccine developed to protect dogs against VL, but which is also meant to prevent transmission of VL to humans, the developers should show that after the vaccinated dog has been challenged with Leishmania, it does not transmit Leishmania to sand flies.</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'>John R David, M.D.<o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>Richard Pearson Strong Professor Emeritus</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>Department of Immunology and Infectious Diseases</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>Harvard School of Public Health</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>Professor of Medicine, Harvard Medical School</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>300 W. 23rd Street, Apt. 13K</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>New York, NY, 10011</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>Tel: 212 414 8646</span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;text-autospace:none'><span style='font-family:"Helvetica","sans-serif"'>Email: <a href="mailto:jdavid@hsph.harvard.edu">jdavid@hsph.harvard.edu</a></span><o:p></o:p></p><p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto'><span style='font-family:"Helvetica","sans-serif"'> </span><o:p></o:p></p><div><div><p class=MsoNormal><o:p> </o:p></p></div><div><p class=MsoNormal>On Sep 19, 2011, at 12:04 AM, Dr GR Rajasekariah wrote:<o:p></o:p></p></div><p class=MsoNormal><br><br><o:p></o:p></p><div><p class=MsoNormal>Hello EveryOne,<br>I am responding to the topic on European VL Dog vaccine.<br>It is a great challenge in devising a protective vaccine against visceral leishmaniasis in dogs. This point equally applies the same challenge for human situation.<br>Because Th-2 response is so dominant during VL infection, modulating Th-2 into Th-1 response is a big challenge to immunologists.<br><br>Key points lies in the presentation of appropriate antigen in appropriate dose to stimulate the Th-1 dependent protective immune response.<br>I understand several vaccines are in the market and real efficacy of these vaccines will come out once introduced to field conditions.<br><br>I just wanted to inform you that we have a suitable antibody kit for testing the immunopotentiation in dogs following vaccination of dogs.<br>Our assay is based on the released promastigote antigens.<br>It is a highly sensitive assay.<br>Currently we supply reagents for determination of total IgG antibodies in serum.<br>If any particular group is interested then we are able to provide appropriate reagent for detection of specific IgG2 and other isotype specific antibody detection.<br>Because our antibody detection ELISA is based on the exo-antigens such an ELISA would be of exceptional type for measuring antibody response in vaccinated animals.<br>Highly suitable for diagnosing dogs responded to vaccines.<br><br>Recently I came to know that some of commercial kits were found to be not useful for detecting seroconversion in dogs vaccinated with FML vaccine (Leish-Immune) in Brazil.<br>Because we use released antigens in our kit, any such problems will overcome if they use Canine Leish IgG CELISA (Manufacturer Cellabs Pty Ltd Brookvale NSW Australia email <a href="mailto:sales@cellabs.com.au">sales@cellabs.com.au</a>).<br>If any one is interested to know more about our antibody detection ELISA based on exo-antigens please contact us.<br><br>This is for your kind information.<br><br>Dr GR Rajasekariah<br>Sydney<br>Australia<br><a href="mailto:raj@cellabs.com.au">raj@cellabs.com.au</a><br><br><br><br><br><br><br>----- Original Message ----- From: <leish-l-request@lineu.icb.usp.br><br>To: <leish-l@lineu.icb.usp.br><br>Sent: Wednesday, August 10, 2011 5:18 PM<br>Subject: Leish-l Digest, Vol 44, Issue 3<br><br><br><br><o:p></o:p></p><p class=MsoNormal>Send Leish-l mailing list submissions to<o:p></o:p></p><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>leish-l@lineu.icb.usp.br<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>To subscribe or unsubscribe via the World Wide Web, visit<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>or, via email, send a message with subject or body 'help' to<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>leish-l-request@lineu.icb.usp.br<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>You can reach the person managing the list at<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>leish-l-owner@lineu.icb.usp.br<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>When replying, please edit your Subject line so it is more specific<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>than "Re: Contents of Leish-l digest..."<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Today's Topics:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 1. European VL Dog Vaccine - CaniLeish?: (jeffrey shaw)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 2. Re: FW: Leishmaniasis Pathology Network (Moazzem Hossain)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 3. Re: FW: Leishmaniasis Pathology Network (Moazzem Hossain)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>----------------------------------------------------------------------<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Message: 1<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Date: Tue, 9 Aug 2011 15:18:44 +0000<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>From: jeffrey shaw <jayusp@hotmail.com><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Subject: [Leish-l] European VL Dog Vaccine - CaniLeish?:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>To: Leish-L <leish-l@lineu.icb.usp.br><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Message-ID: <COL101-W1CDD4171D44B715B795E9CB200@phx.gbl><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Content-Type: text/plain; charset="windows-1252"<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>CaniLeish?:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> The European Commission granted a marketing authorisation valid throughout the European Union, for CaniLeish to Virbac S.A. on 14/03/2011.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> This vaccine, CaniLeish?, will initially be launched in Portugal at the end of the first half of 2011. This will be followed rapidly by launches in other countries in the endemic area: Spain, France, Greece and Italy (not in chronological order). This roll-out takes account of the geographical prevalence of the disease and the time required to build vaccine production up to full capacity. The launch in Northern European countries from where there is a flow of summer visitors to the endemic area will be part of a second phase.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> The basis of this vaccine are excreted proteins plus a saponin adjuvant purified from Quil-A. Its efficacy was determined in a 2 year open field trial.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> The vaccine is given to dogs as three injections, three weeks apart, under the skin. The first injection can be given from six months of age, the second injection is given three weeks later and the third three weeks from the second one. Afterward a single ?booster? should be given every year to maintain protection.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>-------------- next part --------------<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>An HTML attachment was scrubbed...<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110809/f2404f5e/attachment-0001.htm><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>------------------------------<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Message: 2<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Date: Wed, 10 Aug 2011 13:07:17 +0600<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>From: Moazzem Hossain <directordcbd@gmail.com><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Subject: Re: [Leish-l] FW: Leishmaniasis Pathology Network<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>To: jeffrey shaw <jayusp@hotmail.com>, "Prof. Paul Kaye"<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><paul.kaye@york.ac.uk><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Cc: "Prof. Dr. Moazzem Hossain" <profdrmoazzemhossain@gmail.com>,<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Leish-L <leish-l@lineu.icb.usp.br><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Message-ID:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><CAE-TCmS=i=WaT8cAeOXUJmot=KPvMQSLKar6CTfuUBK9M9tsUw@mail.gmail.com><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Content-Type: text/plain; charset=windows-1252<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>10 Aug 2011<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Dear Professor Paul Kaye,<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Thank you for your email. Please find attached our supportive letter<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>of interest for Leishmaniasis Pathology Network.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Looking forward for your kind response.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Best regards.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>-- <o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>*Prof. Dr. Moazzem Hossain *<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Ex - Director Disease Control<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Ministry of Health & Family Welfare<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Government of Bangladesh<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>*Mailing address*:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Founder Chairman and Project Director<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Institute of Allergy & Clinical Immunology of Bangladesh (IACIB)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Room 4 - 5 (2nd Floor), Green Super Market, Green Road<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Dhaka -1205, Bangladesh.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Phone:880-2-8115646 (O )<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 880-1715038551(Mobile)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email: directordcbd@gmail.com<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>On 8/9/11, jeffrey shaw <jayusp@hotmail.com> wrote:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Date: Tue, 9 Aug 2011 11:58:52 +0100<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>From: paul.kaye@york.ac.uk<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Subject: Leishmaniasis Pathology Network<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Dear all,<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Invitation to participate in a global pathology<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> network for<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> research and training in leishmaniasis (LeishPathNet)<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> You may recall the Dormy House meeting in 2008<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> and some of<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the plans we put forward? Over<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the past<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> couple years, I have also spoken more to a few of you about one<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> idea that was<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> formulated at Dormy, namely of setting up a digital pathology<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> network. I have<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> also had numerous discussions with the major equipment<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> manufacturers to see if<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> any of them would be supportive of helping us to develop such an<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> initiative. There have<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> been two major<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> develoments recently. First,<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Carl Zeiss<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> is willing to work with us to set up an integrated global digital<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> pathology<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> network (providing a significant financial and technical<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> contribution) and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> second, the Wellcome Trust is willing to review a pre-proposal to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> fund the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> initiative through their new Biomedical Resources Grant scheme<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>(http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm)<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> .<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> I have attached an outline of the project that<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> I had sent to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the Trust for their initial views, which I think is reasonably<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> self-explanatory.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> They appeared very<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> enthusiastic! The main<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> question now is whether enough of<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> you are still supportive? [ I will also be sending this email to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> others, but please feel free to circulate ]<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> I think the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> project will be<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> challenging, but success could have a real impact on the way we<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> conduct<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> business. It should serve not only as a vehicle to enhance<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> research in<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> leishmaniasis, but the model would be equally applicable across<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> a broad range<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> of diseases and global challenges (with leishmaniasis setting<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the pace).<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> If we wish to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> proceed, the requirements<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> are that we submit a pre-proposal to the Trust by Oct 18th 2011.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> This pre-proposal is short (4 sections of 350 words) and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> requires<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> letters of support from the community.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> If you are<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> supportive of the idea that<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> we try to take this forward (and there is plenty of scope for<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> later iteration<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> of the detail), I would be grateful if you could please provide<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> me with a<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> letter of support by September<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 12th<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 2011, indicating whether you would like to be a network<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> partner if the bid<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> is successful. You could<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> also be<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> supportive but not wish to become directly involved at this<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> stage, and such<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> letters are equally valuable. Your letter might also stress the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> added value<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> that the network could provide, its importance for research and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> training and/or<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> for progressing the translational agenda.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> It would also be an opportunity to indicate whether your<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> group (or<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> institute, if multiple groups) would be interested in bidding to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> be one of the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> initial ?designated laboratories?.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> If there is<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> sufficient support to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> proceed and if subsequently the pre-proposal is successful (we<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> will know on 22nd<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Nov), then I will need a few volunteers to help finalise the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> full proposal,<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> which will be due on Jan 26th 2012.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> A funding decision will be made on May 26th<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 2012.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Best wishes<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> and of course I am happy to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> discuss any points further (though I will be out of the UK from<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Aug 10 ?Sept<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 12)<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Paul<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> --<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Professor Paul Kaye, Ph.D., FRCPath.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Deputy Dean (Research), Hull York Medical School, and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Director, Centre for Immunology and Infection<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Department of Biology and Hull York Medical School<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>University of York<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Wentworth Way<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>York YO10 5YW<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>United Kingdom<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Tel: +44 (0)1904 328840<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Fax: +44 (0)1904 328844<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email: paul.kaye@york.ac.uk <mailto:paul.kaye@york.ac.uk><o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Centre Administrator and PA: Elizabeth Greensted<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Tel: 01904 328845<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email: liz.greensted@york.ac.uk <mailto:liz.greensted@york.ac.uk><o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Centre Email: cii@york.ac.uk <mailto:cii@york.ac.uk><o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Centre website: http://www.york.ac.uk/cii<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Times Higher Education University of the Year 2010<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email disclaimer: http://www.york.ac.uk/docs/disclaimer/email.htm<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>------------------------------<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Message: 3<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Date: Wed, 10 Aug 2011 13:06:47 +0600<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>From: Moazzem Hossain <directordcbd@gmail.com><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Subject: Re: [Leish-l] FW: Leishmaniasis Pathology Network<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>To: jeffrey shaw <jayusp@hotmail.com>, "Prof. Paul Kaye"<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><paul.kaye@york.ac.uk><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Cc: "Prof. Dr. Moazzem Hossain" <profdrmoazzemhossain@gmail.com>,<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Leish-L <leish-l@lineu.icb.usp.br><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Message-ID:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><CAE-TCmQNUkZdNE5w+Z20bjLC-=vvV9BCP6OLOm9f6RV-BfpXvA@mail.gmail.com><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Content-Type: text/plain; charset="windows-1252"<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>10 Aug 2011<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Dear Professor Paul Kaye,<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Thank you for your email. Please find attached our supportive letter<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>of interest for Leishmaniasis Pathology Network.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Looking forward for your kind response.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Best regards.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>-- <o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>*Prof. Dr. Moazzem Hossain *<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Ex - Director Disease Control<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Ministry of Health & Family Welfare<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Government of Bangladesh<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>*Mailing address*:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Founder Chairman and Project Director<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Institute of Allergy & Clinical Immunology of Bangladesh (IACIB)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Room 4 - 5 (2nd Floor), Green Super Market, Green Road<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Dhaka -1205, Bangladesh.<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Phone:880-2-8115646 (O )<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 880-1715038551(Mobile)<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email: directordcbd@gmail.com<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>On 8/9/11, jeffrey shaw <jayusp@hotmail.com> wrote:<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Date: Tue, 9 Aug 2011 11:58:52 +0100<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>From: paul.kaye@york.ac.uk<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Subject: Leishmaniasis Pathology Network<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Dear all,<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Invitation to participate in a global pathology<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> network for<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> research and training in leishmaniasis (LeishPathNet)<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> You may recall the Dormy House meeting in 2008<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> and some of<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the plans we put forward? Over<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the past<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> couple years, I have also spoken more to a few of you about one<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> idea that was<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> formulated at Dormy, namely of setting up a digital pathology<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> network. I have<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> also had numerous discussions with the major equipment<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> manufacturers to see if<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> any of them would be supportive of helping us to develop such an<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> initiative. There have<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> been two major<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> develoments recently. First,<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Carl Zeiss<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> is willing to work with us to set up an integrated global digital<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> pathology<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> network (providing a significant financial and technical<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> contribution) and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> second, the Wellcome Trust is willing to review a pre-proposal to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> fund the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> initiative through their new Biomedical Resources Grant scheme<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>(http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Strategic-awards-and-initiatives/wtdv031727.htm)<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> .<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> I have attached an outline of the project that<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> I had sent to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the Trust for their initial views, which I think is reasonably<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> self-explanatory.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> They appeared very<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> enthusiastic! The main<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> question now is whether enough of<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> you are still supportive? [ I will also be sending this email to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> others, but please feel free to circulate ]<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> I think the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> project will be<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> challenging, but success could have a real impact on the way we<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> conduct<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> business. It should serve not only as a vehicle to enhance<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> research in<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> leishmaniasis, but the model would be equally applicable across<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> a broad range<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> of diseases and global challenges (with leishmaniasis setting<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> the pace).<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> If we wish to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> proceed, the requirements<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> are that we submit a pre-proposal to the Trust by Oct 18th 2011.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> This pre-proposal is short (4 sections of 350 words) and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> requires<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> letters of support from the community.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> If you are<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> supportive of the idea that<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> we try to take this forward (and there is plenty of scope for<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> later iteration<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> of the detail), I would be grateful if you could please provide<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> me with a<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> letter of support by September<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 12th<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 2011, indicating whether you would like to be a network<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> partner if the bid<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> is successful. You could<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> also be<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> supportive but not wish to become directly involved at this<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> stage, and such<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> letters are equally valuable. Your letter might also stress the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> added value<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> that the network could provide, its importance for research and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> training and/or<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> for progressing the translational agenda.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> It would also be an opportunity to indicate whether your<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> group (or<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> institute, if multiple groups) would be interested in bidding to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> be one of the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> initial ?designated laboratories?.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> If there is<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> sufficient support to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> proceed and if subsequently the pre-proposal is successful (we<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> will know on 22nd<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Nov), then I will need a few volunteers to help finalise the<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> full proposal,<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> which will be due on Jan 26th 2012.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> A funding decision will be made on May 26th<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 2012.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Best wishes<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> and of course I am happy to<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> discuss any points further (though I will be out of the UK from<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Aug 10 ?Sept<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> 12)<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> Paul<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal> --<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Professor Paul Kaye, Ph.D., FRCPath.<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Deputy Dean (Research), Hull York Medical School, and<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Director, Centre for Immunology and Infection<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Department of Biology and Hull York Medical School<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>University of York<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Wentworth Way<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>York YO10 5YW<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>United Kingdom<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Tel: +44 (0)1904 328840<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Fax: +44 (0)1904 328844<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email: paul.kaye@york.ac.uk <mailto:paul.kaye@york.ac.uk><o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Centre Administrator and PA: Elizabeth Greensted<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Tel: 01904 328845<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email: liz.greensted@york.ac.uk <mailto:liz.greensted@york.ac.uk><o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Centre Email: cii@york.ac.uk <mailto:cii@york.ac.uk><o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Centre website: http://www.york.ac.uk/cii<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Times Higher Education University of the Year 2010<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Email disclaimer: http://www.york.ac.uk/docs/disclaimer/email.htm<o:p></o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>-------------- next part --------------<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>A non-text attachment was scrubbed...<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Name: Letter Leish UK.doc<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Type: application/msword<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Size: 46080 bytes<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Desc: not available<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20110810/73f2ae6a/attachment.doc><o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>------------------------------<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>_______________________________________________<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Leish-l mailing list<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>Leish-l@lineu.icb.usp.br<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal><o:p> </o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>End of Leish-l Digest, Vol 44, Issue 3<o:p></o:p></p></blockquote><blockquote style='margin-top:5.0pt;margin-bottom:5.0pt'><p class=MsoNormal>************************************** <o:p></o:p></p></blockquote><p class=MsoNormal><br><br><br><br><br>=======<br>Email scanned by PC Tools - No viruses or spyware found.<br>(Email Guard: 7.0.0.26, Virus/Spyware Database: 6.18330)<br>http://www.pctools.com/<br>=======<br>_______________________________________________<br>Leish-l mailing list<br>Leish-l@lineu.icb.usp.br<br>http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l<o:p></o:p></p></div></div><p class=MsoNormal><o:p> </o:p></p><div><div><div><p style='margin:0cm;margin-bottom:.0001pt'><span style='font-size:10.5pt'><o:p> </o:p></span></p></div></div></div></div></body></html>